|
|
|
Volumn 59, Issue 2, 2005, Pages 519-523
|
|
HCV: immune response and its modifiers in clinical development;Mechanizmy immunologiczne zakazeń HCV--kierunek poszukiwań terapeutycznych.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA INTERFERON;
ANTIVIRUS AGENT;
CONSENSUS INTERFERON;
HEPATITIS C ANTIBODY;
INTERFERON;
INTERFERON ALFACON-1;
RECOMBINANT INTERFERON;
RIBAVIRIN;
DRUG COMBINATION;
DRUG EFFECT;
HEPATITIS C;
HEPATITIS C VIRUS;
HUMAN;
IMMUNOLOGY;
IMMUNOTHERAPY;
METHODOLOGY;
REVIEW;
T LYMPHOCYTE;
VIROLOGY;
ANTIVIRAL AGENTS;
DRUG THERAPY, COMBINATION;
HEPACIVIRUS;
HEPATITIS C ANTIBODIES;
HEPATITIS C, CHRONIC;
HUMANS;
IMMUNOTHERAPY;
INTERFERON TYPE I, RECOMBINANT;
INTERFERON-ALPHA;
INTERFERONS;
RIBAVIRIN;
T-LYMPHOCYTES;
|
|
EID: 32944474631
PISSN: 00332100
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (2)
|
|
References (35)
|
